As a result of the recent Pfizer decision, there is now a circuit split concerning district court jurisdiction for overpayment interest suits. The Sixth Circuit (Scripps) said that jurisdiction is available under 28 U.S.C. sec. 1346(a)(1), regardless of the amount at issue. The Second Circuit (Pfizer) said that jurisdiction for these suits is only available under 28 U.S.C. sec. 1346(a)(1), and is limited to claims of $10,000 or less, thus pushing many suits to the Court of Federal Claims instead. In the Bank of America case, the district court for the Western District of North Carolina agreed with Scripps. The government has now pursued an interlocutory appeal to the Federal Circuit, which has not yet addressed this issue. The blog post also address conflicting policies Congress has expressed, with possible implications for where these suits should be heard.